Ben Bronstein - Net Worth and Insider Trading
Ben Bronstein Net Worth
The estimated net worth of Ben Bronstein is at least $88,745 dollars as of 2024-11-13. Ben Bronstein is the Director of Aldeyra Therapeutics Inc and owns about 18,644 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $88,745. Details can be seen in Ben Bronstein's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ben Bronstein has not made any transactions after 2019-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ben Bronstein
Ben Bronstein Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ben Bronstein owns 1 companies in total, including Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of Ben Bronstein’s form 4 insider trades.
Insider Ownership Summary of Ben Bronstein
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-17 | director |
Ben Bronstein Latest Holdings Summary
Ben Bronstein currently owns a total of 1 stock. Ben Bronstein owns 18,644 shares of Aldeyra Therapeutics Inc (ALDX) as of September 17, 2019, with a value of $88,745.
Latest Holdings of Ben Bronstein
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-17 | 18,644 | 4.76 | 88,745 |
Holding Weightings of Ben Bronstein
Ben Bronstein Form 4 Trading Tracker
According to the SEC Form 4 filings, Ben Bronstein has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 1,700 shares on September 17, 2019, which cost Ben Bronstein around $9,945.
Insider Trading History of Ben Bronstein
- 1
Ben Bronstein Trading Performance
GuruFocus tracks the stock performance after each of Ben Bronstein's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ben Bronstein is -10.62%. GuruFocus also compares Ben Bronstein's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ben Bronstein within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ben Bronstein's insider trading performs compared to the benchmark.
Performance of Ben Bronstein
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.39 | | | | | |
| Relative Return to S&P 500(%) | 1.94 | | | | | |
Ben Bronstein Ownership Network
Ownership Network List of Ben Bronstein
Ownership Network Relation of Ben Bronstein
Ben Bronstein Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
Ben Bronstein is the director of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include Chief Development Officer Stephen Machatha , See Remarks Bruce Greenberg , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Ben Bronstein made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
Ben Bronstein Mailing Address
Above is the net worth, insider trading, and ownership report for Ben Bronstein. You might contact Ben Bronstein via mailing address: 15 New England Executive Park, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
